As of 2025-03-27, the EV/EBITDA ratio of Ikena Oncology Inc (IKNA) is -0.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IKNA's latest enterprise value is 52.34 mil USD. IKNA's TTM EBITDA according to its financial statements is -62.96 mil USD. Dividing these 2 quantities gives us the above IKNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |